Literature DB >> 24139751

Predicting excessive hemorrhage in adolescent idiopathic scoliosis patients undergoing posterior spinal instrumentation and fusion.

Mark E Thompson1, Jessica M Kohring2, Kim McFann3, Bryan McNair3, Jennifer K Hansen4, Nancy H Miller5.   

Abstract

BACKGROUND CONTEXT: Blood loss in patients with adolescent idiopathic scoliosis (AIS) who are undergoing posterior spinal instrumentation and fusion (PSIF) varies greatly. The reason for this wide range is not clear. There are reports of unexpected massive hemorrhage during these surgeries. Many studies reflect authors' preferences for describing blood loss in terms of levels fused, weight, or percent blood volume.
PURPOSE: We sought to define excessive blood loss clinically, determine its incidence in our study population, and identify associated variables. Results are intended to inform perioperative preparation for these cases. Results may be used to inform prospective study designs. STUDY
DESIGN: This was a retrospective uncontrolled case series. PATIENT SAMPLE: A total of 311 consecutive AIS PSIF cases during the years 2005-2010 performed at Children's Hospital Colorado were studied. OUTCOME MEASURES: We measured estimated blood loss (EBL) and its association with multiple patient, surgical, and anesthetic variables.
METHODS: Thirty-one variables potentially related to blood loss were collected retrospectively from electronic medical records for analysis. When no cases of clearly excessive blood loss were identified on the basis of visual examination of EBL distribution, we chose to use the top 10% of blood loss cases as an arbitrary determinant of excessive blood loss. Three cut-off strategies captured the top 10% of EBL cases with little variation in who was selected: 1) >1,700 mL of EBL, 2) >50% EBL/estimated blood volume, and 3) >150 mL/level fused EBL. Variables were compared with the χ(2) test, Fisher exact, or t-tests, when appropriate. A generalized linear mixed logistic model was used to determine the probability of excessive blood loss based on the number of levels fused.
RESULTS: The average EBL was 89.17 mL/level fused (range, 45-133 mL). EBL fit a progressively wider distribution as surgical complexity (number of levels fused) increased. Number of levels fused (p<.0001), operative time (p=.0139), number of screws (p<.0001), and maximal preoperative Cobb angle (p=.0491) were significantly associated with excessive blood loss. The variable that was most strongly associated with excessive blood loss was the number of levels fused, with ≥12 levels having a probability of >10% of excessive hemorrhage.
CONCLUSION: Excessive blood loss may be an arbitrary number until future research suggests otherwise. We show that the probability of exceeding one of our arbitrary definitions is approximately 10% when 12 or more levels are fused. If a 10% incidence of excessive blood loss is determined to be clinically relevant, teams might wish to pursue hematologic consultation and maximal blood conservation strategy when 12 or more levels are planned for fusion.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Estimated blood loss; Hemostatic disorder; Scoliosis; Spinal fusion; Surgical hemorrhage

Mesh:

Year:  2013        PMID: 24139751     DOI: 10.1016/j.spinee.2013.08.022

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  10 in total

1.  Triple Issues Underlying Lung Injury for Adolescent Idiopathic Scoliosis Surgery.

Authors:  Hai-Qiang Wang; Jun Zhang; Chi-Jiao Ma
Journal:  Lung       Date:  2018-05-29       Impact factor: 2.584

2.  Reduced blood loss and operation time in lumbar posterolateral fusion using a bipolar sealer.

Authors:  Daisuke Fukui; Mamoru Kawakami; Shin-Ichi Nakao; Erabu Miyamoto; Shouko Morishita; Toshiko Matuoka; Hiroshi Yamada
Journal:  Eur Spine J       Date:  2016-06-08       Impact factor: 3.134

3.  One-step (standard) versus two-step surgical approach in adolescent idiopathic scoliosis posterior spinal fusion: Which is better?

Authors:  Norman Ramirez; Pablo Valentin; Manuel García-Cartagena; Solais Samalot; Ivan Iriarte
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-05-13

4.  Use of a novel corrective device for correction of deformities in adolescent idiopathic scoliosis.

Authors:  Iain Feeley; Andrew Hughes; Noelle Cassidy; Connor Green
Journal:  Ir J Med Sci       Date:  2019-05-18       Impact factor: 1.568

5.  Risk Factors of Total Blood Loss and Hidden Blood Loss in Patients with Adolescent Idiopathic Scoliosis: A Retrospective Study.

Authors:  Xiangyu Li; Wenyuan Ding; Ruoyu Zhao; Sidong Yang
Journal:  Biomed Res Int       Date:  2022-05-27       Impact factor: 3.246

6.  Gender of patients and level of osteotomy are predictive factors for blood loss in ankylosing spondylitis patients undergoing pedicle subtraction osteotomy.

Authors:  Yanjun Liu; Zhengliang Ma; Xiaoping Gu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Incidence, influencing factors, and prognostic impact of intraoperative massive blood loss in adolescents with neuromuscular scoliosis: A STROBE-compliant retrospective observational analysis.

Authors:  Rui Jia; Na Li; Bi-Yun Xu; Wei Zhang; Xiao-Ping Gu; Zheng-Liang Ma
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Blood Management and Risk Assessment for Transfusion in Pediatric Spinal Deformity Surgery.

Authors:  Pedro Fernandes; Joaquim Soares do Brito; Isabel Flores; Jacinto Monteiro
Journal:  Adv Hematol       Date:  2020-05-07

9.  Preoperative Mechanical Bowel Evacuation Reduces Intraoperative Bleeding and Operation Time in Spinal Surgery.

Authors:  Majid Rezvani; Reza Abbasi; Homayoon Tabesh; Leila Dehghani; Shahaboddin Dolatkhah; Maryam Nasri; Mohsen Kolahdouzan; Rokhsareh Meamar
Journal:  Asian Spine J       Date:  2018-06-04

10.  COMPARISON OF IMPLANT DENSITY IN THE MANAGEMENT OF LENKE 1B AND 1C ADOLESCENT IDIOPATHIC SCOLIOSIS.

Authors:  Bekir Eray Kilinc; Dong Phuong Tran; Charles Johnston
Journal:  Acta Ortop Bras       Date:  2019 Jan-Feb       Impact factor: 0.513

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.